Skip to main content

Advertisement

Log in

Prostate cancer staging with extracapsular extension risk scoring using multiparametric MRI: a correlation with histopathology

  • Urogenital
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

To evaluate the diagnostic performance of preoperative multiparametric MRI with extracapsular extension (ECE) risk-scoring in the assessment of prostate cancer tumour stage (T-stage) and prediction of ECE at final pathology.

Materials and Methods

Eighty-seven patients with clinically localised prostate cancer scheduled for radical prostatectomy were prospectively enrolled. Multiparametric MRI was performed prior to prostatectomy, and evaluated according to the ESUR MR prostate guidelines by two different readers. An MRI clinical T-stage (cTMRI), an ECE risk score, and suspicion of ECE based on tumour characteristics and personal opinion were assigned. Histopathological prostatectomy results were standard reference.

Results

Histopathology and cTMRI showed a spearman rho correlation of 0.658 (p < 0.001) and a weighted kappa = 0.585 [CI 0.44;0.73](reader A). ECE was present in 31/87 (36 %) patients. ECE risk-scoring showed an AUC of 0.65–0.86 on ROC-curve for both readers, with sensitivity and specificity of 81 % and 78 % at best cutoff level (reader A), respectively. When tumour characteristics were influenced by personal opinion, the sensitivity and specificity for prediction of ECE changed to 61 %–74 % and 77 %-88 % for the readers, respectively.

Conclusions

Multiparametric MRI with ECE risk-scoring is an accurate diagnostic technique in determining prostate cancer clinical tumour stage and ECE at final pathology.

Key Points

Multiparametric MRI is an accurate diagnostic technique for preoperative prostate cancer staging

ECE risk scoring predicts extracapsular tumour extension at final pathology

ECE risk scoring shows an AUC of 0.86 on the ROC-curve

ECE risk scoring shows a moderate inter-reader agreement (K = 0.45)

Multiparametric MRI provides essential knowledge for optimal clinical management

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

DRE:

Digital rectal examination

TRUS:

Transrectal ultrasound

PCa:

Prostate cancer

EPE:

Extraprostatic tumour extension

RP:

Radical prostatectomy

cT:

Clinical tumour stage

NVB:

Neurovascular bundle

MRI:

Magnetic resonance imaging

Mp-MRI:

Multiparametric MRI

PIRADS:

Prostate imaging reporting and data system

T2W:

T2-weighted

DWI:

Diffusion-weighted imaging

ADC:

Apparent diffusion coefficient

DCE:

Dynamic contrast-enhanced

ECE:

Extracapsular extension

SVI:

Seminal vesicle invasion

GS:

Gleason score

ERC:

Endorectal coil

References

  1. Heidenreich A, Bastian PJ, Bellmunt J et al (2014) EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol 65:124–137

    Article  PubMed  Google Scholar 

  2. Mullerad M, Hricak H, Kuroiwa K et al (2005) Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. J Urol 174:2158–2163

    Article  PubMed  Google Scholar 

  3. Grossfeld GD, Chang JJ, Broering JM et al (2001) Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database. J Urol 165:851–856

    Article  CAS  PubMed  Google Scholar 

  4. Soulié M (2008) What is the role of surgery for locally advanced disease? Eur Urol Suppl 7:400–405

    Article  Google Scholar 

  5. Sciarra A, Barentsz J, Bjartell A et al (2011) Advances in magnetic resonance imaging: how they are changing the management of prostate cancer. Eur Urol 59:962–977

    Article  PubMed  Google Scholar 

  6. Fütterer JJ, Engelbrecht MR, Jager GJ et al (2007) Prostate cancer: comparison of local staging accuracy of pelvic phased-array coil alone versus integrated endorectal-pelvic phased-array coils. Local staging accuracy of prostate cancer using endorectal coil MR imaging. Eur Radiol 17:1055–1065

    Article  PubMed  Google Scholar 

  7. Mullerad M, Hricak H, Wang L, Chen H-N, Kattan MW, Scardino PT (2004) Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging. Radiology 232:140–146

    Article  PubMed  Google Scholar 

  8. Brajtbord JS, Lavery HJ, Nabizada-Pace F, Senaratne P, Samadi DB (2011) Endorectal magnetic resonance imaging has limited clinical ability to preoperatively predict pT3 prostate cancer. BJU Int 107:1419–1424

    Article  PubMed  Google Scholar 

  9. Hegde JV, Chen M-H, Mulkern RV, Fennessy FM, D’Amico AV, Tempany CMC (2013) Preoperative 3-Tesla multiparametric endorectal magnetic resonance imaging findings and the odds of upgrading and upstaging at radical prostatectomy in men with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 85:101–107

    Article  Google Scholar 

  10. Renard-Penna R, Rouprêt M, Comperat E et al (2013) Accuracy of high resolution (1.5 tesla) pelvic phased array magnetic resonance imaging (MRI) in staging prostate cancer in candidates for radical prostatectomy: results from a prospective study. Urol Oncol 31:448–454

    Article  PubMed  Google Scholar 

  11. Heidenreich A (2011) Consensus criteria for the use of magnetic resonance imaging in the diagnosis and staging of prostate cancer: not ready for routine use. Eur Urol 59:495–497

    Article  PubMed  Google Scholar 

  12. Barentsz JO, Richenberg J, Clements R et al (2012) ESUR prostate MR guidelines 2012. Eur Radiol 22:746–757

    Article  PubMed Central  PubMed  Google Scholar 

  13. Portalez D, Mozer P, Cornud F et al (2012) Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients. Eur Urol 62:986–996

    Article  PubMed  Google Scholar 

  14. Röthke M, Blondin D, Schlemmer H-P, Franiel T (2013) PI-RADS classification: structured reporting for MRI of the prostate. Röfo 185:253–261

    PubMed  Google Scholar 

  15. Boesen L, Noergaard N, Chabanova E et al (2014) Early experience with multiparametric magnetic resonance imaging-targeted biopsies under visual transrectal ultrasound guidance in patients suspicious for prostate cancer undergoing repeated biopsy. Scand J Urol. doi:10.3109/21681805.2014.9

    PubMed  Google Scholar 

  16. Rosenkrantz AB, Kim S, Lim RP et al (2013) Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales. Radiology 269:482–492

    Article  PubMed  Google Scholar 

  17. Roethke MC, Kuru TH, Schultze S et al (2014) Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla. Eur Radiol 24:344–352

    Article  CAS  PubMed  Google Scholar 

  18. Sobin L, Gospodarowicz MWC (2009) TNM classification of malignant tumours. Urological tumours, 7th edn. Wiley-Blackwell, Hoboken

    Google Scholar 

  19. Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174

    Article  CAS  PubMed  Google Scholar 

  20. Rosenkrantz AB, Chandarana H, Gilet A et al (2013) Prostate cancer: utility of diffusion-weighted imaging as a marker of side-specific risk of extracapsular extension. J Magn Reson Imaging 38:312–319

    Article  PubMed  Google Scholar 

  21. Chong Y, Kim CK, Park SY, Park BK, Kwon GY, Park JJ (2014) Value of diffusion-weighted imaging at 3 T for prediction of extracapsular extension in patients with prostate cancer: a preliminary study. AJR Am J Roentgenol 202:772–777

    Article  PubMed  Google Scholar 

  22. Bloch BN, Furman-Haran E, Helbich TH et al (2007) Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging–initial results. Radiology 245:176–185

    Article  PubMed  Google Scholar 

  23. Fütterer JJ, Engelbrecht MR, Huisman HJ et al (2005) Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. Radiology 237:541–549

    Article  PubMed  Google Scholar 

  24. Engelbrecht MR, Jager GJ, Laheij RJ, Verbeek ALM, van Lier HJ, Barentsz JO (2002) Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis. Eur Radiol 12:2294–2302

    Article  PubMed  Google Scholar 

  25. Fütterer JJ, Heijmink SWTPJ, Scheenen TWJ et al (2006) Prostate cancer: local staging at 3-T endorectal MR imaging–early experience. Radiology 238:184–191

    Article  PubMed  Google Scholar 

  26. Heijmink SWTPJ, Fütterer JJ, Hambrock T et al (2007) Prostate cancer: body-array versus endorectal coil MR imaging at 3 T–comparison of image quality, localization, and staging performance. Radiology 244:184–195

    Article  PubMed  Google Scholar 

  27. Ward JF, Slezak JM, Blute ML, Bergstralh EJ, Zincke H (2005) Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. BJU Int 95:751–756

    Article  PubMed  Google Scholar 

  28. Hsu C-Y, Joniau S, Oyen R, Roskams T, Van Poppel H (2007) Outcome of surgery for clinical unilateral T3a prostate cancer: a single-institution experience. Eur Urol 51:121–128, discussion 128–9

    Article  PubMed  Google Scholar 

  29. Mitchell CR, Boorjian SA, Umbreit EC, Rangel LJ, Carlson RE, Karnes RJ (2012) 20-Year survival after radical prostatectomy as initial treatment for cT3 prostate cancer. BJU Int 110:1709–1713

    Article  PubMed  Google Scholar 

  30. Spahn M, Briganti A, Capitanio U et al (2012) Outcome predictors of radical prostatectomy followed by adjuvant androgen deprivation in patients with clinical high risk prostate cancer and pT3 surgical margin positive disease. J Urol 188:84–90

    Article  PubMed  Google Scholar 

  31. Wang L, Hricak H, Kattan MW, Chen H-N, Scardino PT, Kuroiwa K (2006) Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms. Radiology 238:597–603

    Article  PubMed  Google Scholar 

  32. Shukla-Dave A, Hricak H, Akin O et al (2012) Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer. BJU Int 109:1315–1322

    Article  PubMed Central  PubMed  Google Scholar 

  33. Ruprecht O, Weisser P, Bodelle B, Ackermann H, Vogl TJ (2012) MRI of the prostate: interobserver agreement compared with histopathologic outcome after radical prostatectomy. Eur J Radiol 81:456–460

    Article  PubMed  Google Scholar 

  34. Garcia-Reyes K, Passoni NM, Palmeri ML et al (2014) Detection of prostate cancer with multiparametric MRI (mpMRI): effect of dedicated reader education on accuracy and confidence of index and anterior cancer diagnosis. Abdom Imaging. doi:10.1007/s00261-014-019

    Google Scholar 

  35. Turkbey B, Merino MJ, Gallardo EC et al (2014) Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: correlation with whole-mount histopathology. J Magn Reson Imaging 39:1443–1448

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The scientific guarantor of this publication is Henrik S. Thomsen. The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article. The authors state that this work has not received any funding. No complex statistical methods were necessary for this paper. Institutional Review Board approval was obtained. Written informed consent was obtained from all subjects (patients) in this study. Approval from the institutional animal care committee was not required because the study was not on animals. Methodology: prospective, diagnostic, or prognostic study, performed at one institution.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lars Boesen.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Boesen, L., Chabanova, E., Løgager, V. et al. Prostate cancer staging with extracapsular extension risk scoring using multiparametric MRI: a correlation with histopathology. Eur Radiol 25, 1776–1785 (2015). https://doi.org/10.1007/s00330-014-3543-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-014-3543-9

Keywords

Navigation